Antipsychotic medications are not a cure for schizophrenia, for the moment we hope. They only treat the symptoms and help to normalize the biochemical imbalances that cause schizophrenia. There are two major types of antips…
Bipolar affective disorder, also known as manic depression disorder, is a mental illness that causes the patient to experience mood swings or mood cycling, involving depressive episodes, mania episodes, and/or mixed episodes. There are many treatment options for bipolar affective di…
DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/reports/c47375) has announced the addition of Otsuka Prospects to 2010 from Espicom Business Intelligence to their offering.
Pharmaceutical company intelligence reports provide a full review of the company’s a…
LENEXA, Kan. — CyDex, Inc., a specialty pharmaceutical company developing improved products through innovative drug delivery, today announced that a subcutaneous injection formulation of the veterinary anti-emetic medication Cerenia([R])(maropitant) from Pfizer Limited contains CyDex’s Captisol([R])-enabling technology.
On September 29, 2006, the European Medicines Agency approved both the subcutaneous injection and tablet formulations of Pfizer’s Cerenia for marketing through…
May 7, 2008 (Washington) — Children who are taking antipsychotic drugs should be regularly monitored for potentially dangerous changes in body fat and lipids (blood fat).
So says a researcher who found that kids experienced almost immediate increases in body mass index (BMI) and triglyceride levels after they started taking the drugs.
On…
Drugmaker Bristol-Myers Squibb said Thursday that it would pay $499 million to settle federal investigations into its pricing, sales and marketing practices. The tentative agreement is one of the biggest in recent years for drugmakers regarding drug marketing and pricing. It aims to settle investigations into Bristol’s marketing of schizophrenia and bipolar disorder drug Abilify for conditions the drug was not approved to treat, says Bristol spokesma…
By Jeff Swiatek, The Indianapolis Star Knight Ridder/Tribune Business News
Apr. 23–The Prozac blahs seem over for Eli Lilly and Co., which on Tuesday reported its highest sales jump since the patent on its famous antidepressant expired nearly two years ago.
Sales from January through March grew 13 percent, to $2.89 billion, over the same period a year ago, the drugmaker said Tuesday.
Most Popular
Today’s Best Part-Time J…
